Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • avi
    Junior Member
    • Mar 2011
    • 7

    #1

    Transcript mapping stats from Cuffcompare - Does this look right to you?

    Hi all,

    I am working on some RNAseq data (Single end reads,36 bp from an Illumina instrument) from a prostrate cancer cell line. All I have for this is a Fasta file of all the reads.

    I have assembled the reads using Tophat and Cufflinks, and then ran Cuffcompare to look at the quality of transcriptome reconstruction. This was the profile of transfrags I got.

    HTML Code:
    Category     No.of transfrags    % of total
    Match	          1533	               1.73
    Novel	          3561	               4.02
    Contained	  24080	               27.18
    Repeat	           0	                0
    Intronic	  10115	               11.42
    Polymerase        1889	               2.13
     run-on	
    Intergenic	  28752	               32.46
    Overlap on        14340	               16.19
    opp.strand	
    Total	          88580	               100
    [I just grep'ed the tmap file to find no of rows with each class code]

    I am new to RNAseq data, so I have no idea what to expect. But I find it surprising to see that only 1.73% of the total transfrags matched to a known transcript. And that over 32% mapped to intergenic regions. Even accounting for the fact that it is a cancer cell line and some amount of changes are to be expected.

    I was hoping someone with experience could take a look at this and give their opinion. Are these kind of numbers common..? Or does this mean the data I got has some problems?

    Also, in general.. are there any standard quality assurance steps I can use to check RNAseq data?

    Would greatly appreciate any help that I can get on this..

    thanks..!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...